Patient and Therapy Considerations Guiding Initiation of Treatment in RET-Positive NSCLC

Panelists discuss their initial impressions of a patient case with RET fusion–positive non–small cell lung cancer (NSCLC), treatment goals for newly diagnosed patients, and the key patient and disease characteristics considered when selecting a first-line treatment regimen.

EP: 1.Patient Case: 67 Year-Old Male With Stage IIIB+ NSCLC Awaiting for Mutation Testing

EP: 2.Next Steps to Stage IIIB NSCLC Patient Case Awaiting Molecular Testing and Usability of Liquid Biopsy

EP: 3.Testing Methodologies and Standards in Metastatic NSCLC

EP: 4.Practical Considerations in Metastatic NSCLC: Access and Timing of Testing

EP: 5.Clinical-Decision Making: When to Treat Advanced NSCLC Without Mutational Results

EP: 6.Initial Approach to Management of RET-Positive NSCLC

Now Viewing

EP: 7.Patient and Therapy Considerations Guiding Initiation of Treatment in RET-Positive NSCLC

1. Dr Sands to Dr Wakelee: What are your initial impressions of this case? How might you have treated this patient in your practice?
2. Dr Wakelee to Dr Sands: What are your treatment goals for patients newly diagnosed with RET fusion–positive NSCLC?
3. Dr Sands: Describe which patient and disease characteristics you consider when selecting a first-line treatment regimen.

Related Videos